Propanc Biopharma, Inc., a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, announced that the joint research partnership with the Universities of Jaén and Granada, Spain, is entering its thirteenth year since their collaboration began in 2009.
February 23, 2022
· 9 min read